ADAGIO THERAPEUTICS INC's ticker is and the CUSIP is 00534A102. A total of 77 filers reported holding ADAGIO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,923,374 | +39.0% | 1,131,396 | -14.1% | 0.00% | – |
| Q2 2023 | $1,383,590 | -69.4% | 1,317,705 | -65.1% | 0.00% | – |
| Q1 2023 | $4,526,684 | -22.2% | 3,772,236 | -2.7% | 0.00% | – |
| Q4 2022 | $5,815,566 | -46.6% | 3,877,043 | +11.4% | 0.00% | – |
| Q3 2022 | $10,893,000 | +7.2% | 3,480,633 | +12.3% | 0.00% | – |
| Q2 2022 | $10,166,000 | -24.5% | 3,099,632 | +5.0% | 0.00% | – |
| Q1 2022 | $13,460,000 | +41.8% | 2,951,595 | +125.8% | 0.00% | – |
| Q4 2021 | $9,490,000 | -83.1% | 1,307,267 | -1.6% | 0.00% | -100.0% |
| Q3 2021 | $56,138,000 | – | 1,329,055 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 9,248,250 | $13,872,375 | 13.22% |
| Alphabet Inc. | 5,680,785 | $8,521,178 | 0.50% |
| 683 Capital Management, LLC | 3,000,000 | $4,500,001 | 0.38% |
| Bain Capital Life Sciences Investors, LLC | 1,937,207 | $2,906 | 0.32% |
| Slate Path Capital LP | 3,735,000 | $5,602,500 | 0.30% |
| Newtyn Management, LLC | 900,000 | $1,350,000 | 0.28% |
| Orbimed Advisors | 5,270,400 | $7,905,600 | 0.15% |
| Oasis Management Co Ltd. | 348,432 | $522,648 | 0.10% |
| Redmile Group, LLC | 1,440,725 | $2,161,088 | 0.09% |
| Anson Funds Management LP | 154,156 | $231,234 | 0.04% |